Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Cancer × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 39 Breast Neoplasms 31 Prostatic Neoplasms 16 Triple Negative Breast Neoplasms 13 Neoplasms 10 Endometrial Neoplasms 10 Fallopian Tube Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Small Cell Lung Carcinoma 7 Pancreatic Neoplasms 7 Recurrence 6 Carcinoma, Ovarian Epithelial 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Glioma 4 Glioblastoma 4 Advanced Breast Cancer 4 Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Solid Tumor 3 Sarcoma 3 Head and Neck Neoplasms 3 Carcinoma, Squamous Cell 3 Carcinoma, Non-Small-Cell Lung 3 Uveal Melanoma 2 Uterine Neoplasms 2 Urinary Bladder Neoplasms 2 Neuroendocrine Tumors 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2

Interventions

Surveys and Questionnaires 7 Bevacizumab 5 temsirolimus 4 Standard of Care 4 Sirolimus 4 Interviews as Topic 4 Vorinostat 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Erlotinib Hydrochloride 2 Cetuximab 2 zaleplon 1 vistusertib 1 tilsotolimod 1 pazopanib 1 olaparib 1 liposomal doxorubicin 1 capivasertib 1 apatinib 1 Videotape Recording 1 Vemurafenib 1 Valproic Acid 1 Trastuzumab 1 Topotecan 1 Temozolomide 1 Sunitinib 1 Sorafenib 1 Rehabilitation 1 Referral and Consultation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02338622 2024-09-26

ComPAKT

Royal Marsden NHS Foundation Trust

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡